Agilon Health (NYSE:AGL) Price Target Raised to $13.00

Agilon Health (NYSE:AGL) had its target price raised by Benchmark to $13.00 in a research report sent to investors on Thursday,Benzinga reports. Benchmark currently has a buy rating on the stock.

Several other research analysts have also recently weighed in on the company. Barclays reduced their price target on Agilon Health from $25.00 to $12.50 and set an “underweight” rating for the company in a research report on Friday, February 27th. Citigroup lowered their price objective on Agilon Health from $21.25 to $18.75 and set a “neutral” rating on the stock in a research report on Tuesday, March 3rd. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a research note on Wednesday, December 3rd. Wells Fargo & Company lifted their target price on shares of Agilon Health from $25.00 to $37.50 and gave the company an “overweight” rating in a report on Friday, February 27th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Agilon Health has an average rating of “Hold” and a consensus target price of $51.93.

Agilon Health Price Performance

NYSE:AGL opened at $10.66 on Thursday. The firm’s fifty day moving average is $13.69 and its two-hundred day moving average is $18.35. The firm has a market cap of $176.87 million, a price-to-earnings ratio of -0.45 and a beta of 0.33. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. Agilon Health has a one year low of $7.48 and a one year high of $152.00.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). The company had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Agilon Health had a negative net margin of 6.60% and a negative return on equity of 120.82%. Research analysts expect that Agilon Health will post -0.59 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. North Peak Capital Management LLC boosted its holdings in Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after buying an additional 3,715,460 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Agilon Health by 196.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the last quarter. CenterBook Partners LP raised its holdings in shares of Agilon Health by 492.4% during the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock valued at $11,771,000 after acquiring an additional 9,499,012 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Agilon Health by 1,346.6% in the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Agilon Health by 30.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock valued at $5,523,000 after acquiring an additional 1,893,434 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.